Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex

Molecular and Cellular Biology

Volumn 25, Issue 7, 2005, Pages 2708-2721

  Jiang, Wei Qin ^a   Zhong, Ze Huai ^a   Henson, Jeremy D ^a   Neumann, Axel A ^a   Chang, Andy C M ^a   Reddel, Roger R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN; RECOMBINANT PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

ALTERNATIVE LENGTHENING OF TELOMERE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL HETEROGENEITY; CELL NUCLEUS INCLUSION BODY; GENE OVEREXPRESSION; GENE REPRESSION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TELOMERE; TRANSGENE;

CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTEIN BINDING; RNA, SMALL INTERFERING; TELOMERE; TRANSGENES;

EID: 15044357804     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.7.2708-2721.2005     Document Type: Article

References (55)

1. Boulton, S. J., and S. P. Jackson. 1998. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1819-1828.
2. Bressan, D. A., B. K. Baxter, and J. H. J. Petrini. 1999. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based doublestrand break repair in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:7681-7687.
3. Bryan, T. M., A. Englezou, L. Dalla-Pozza, M. A. Dunham, and R. R. Reddel. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1271-1274.
4. Bryan, T. M., A. Englezou, J. Gupta, S. Bacchetti, and R. R. Reddel. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240-4248.
5. Cerone, M. A., J. A. Londono-Vallejo, and S. Bacchetti. 2001. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10:1945-1952.
6. de Lange, T. 2002. Protection of mammalian telomeres. Oncogene 21:532-540.
7. Dellaire, G., and D. P. Bazett-Jones. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26:963-977.
8. Dunham, M. A., A. A. Neumann, C. L. Fasching, and R. R. Reddel. 2000. Telomere maintenance by recombination in human cells. Nat. Genet. 26:447-450.
9. Ford, L. P., Y. Zou, K. Pongracz, S. M. Gryaznov, J. W. Shay, and W. E. Wright. 2001. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276:32198-32203.
10. Greider, C. W., and E. H. Blackburn. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413.
11. 2/M phase of the cell cycle. J. Cell Sci. 113:4577-4585.
12. Grobelny, J. V., M. Kulp-McEliece, and D. Broccoli. 2001. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet. 10:1953-1961.
13. Hakin-Smith, V., D. A. Jellinek, D. Levy, T. Carroll, M. Teo, W. R. Timperley, M. J. McKay, R. R. Reddel, and J. A. Royds. 2003. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836-838.
14. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
15. Johnson, F. B., R. A. Marciniak, M. McVey, S. A. Stewart, W. C. Hahn, and L. Guarente. 2001. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20:905-913.
16. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
17. Kumata, M., M. Shimizu, M. Oshimura, M. Uchida, and T. Tsutsui. 2002. Induction of cellular senescence in a telomerase negative human immortal fibroblast cell line, LCS-AF. 1-3, by human chromosome 6. Int. J. Oncol. 21:851-856.
18. Le, S., J. K. Moore, J. E. Haber, and C. W. Greider. 1999. RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 152:143-152.
19. Lehming, N., A. Le Saux, J. Schuller, and M. Ptashne. 1998. Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95:7322-7326.
20. - senescence. Cell 73:347-360.
21. McEachern, M. J., and S. Iyer. 2001. Short telomeres in yeast are highly recombinogenic. Mol. Cell 7:695-704.
22. Molenaar, C., K. Wiesmeyer, N. P. Verwoerd, S. Khazen, R. Eils, H. J. Tanke, and R. W. Dirks. 2003. Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J. 22:6631-6641.
23. Moller, A., H. Sirma, T. G. Hofmann, H. Staege, E. Gresko, K. S. Ludi, E. Klimczak, W. Droge, H. Will, and M. L. Schmitz. 2003. Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression. Oncogene 22:8731-8737.
24. Muratani, M., D. Gerlich, S. M. Janicki, M. Gebhard, R. Eils, and D. L. Spector. 2001. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol. 4:106-110.
25. Murnane, J. P., L. Sabatier, B. A. Marder, and W. F. Morgan. 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13:4953-4962.
26. Nabetani, A., O. Yokoyama, and F. Ishikawa. 2004. Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J. Biol. Chem. 279:25849-25857.
27. Naka, K., K. Ikeda, and N. Motoyama. 2002. Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem. Biophys. Res. Commun. 299:863-871.
28. Nakabayashi, K., T. Ogata, M. Fujii, H. Tahara, T. Ide, R. Wadhwa, S. C. Kaul, Y. Mitsui, and D. Ayusawa. 1997. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235:345-353.
29. Negorev, D., A. M. Ishov, and G. G. Maul. 2001. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci. 114:59-68.
30. Negorev, D., and G. G. Maul. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20:7234-7242.
31. Nugent, C. I., G. Bosco, L. O. Ross, S. K. Evans, A. P. Salinger, J. K. Moore, J. E. Haber, and V. Lundblad. 1998. Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8:657-660.
32. Perrem, K., T. M. Bryan, A. Englezou, T. Hackl, E. L. Moy, and R. R. Reddel. 1999. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18:3383-3390.
33. Perrem, K., L. M. Colgin, A. A. Neumann, T. R. Yeager, and R. R. Reddel. 2001. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21:3862-3875.
34. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15:4745-4753.
35. Seeler, J.-S., A. Marchio, D. Sitterlin, C. Transy, and A. Dejean. 1998. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95:7316-7321.
36. Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:787-791.
37. Smogorzewska, A., and T. de Lange. 2004. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73:177-208.
38. Stayropoulos, D. J., P. S. Bradshaw, X. Li, I. Pasic, K. Truong, M. Ikura, M. Ungrin, and M. S. Meyn. 2002. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 11:3135-3144.
39. Sternsdorf, T., K. Jensen, B. Reich, and H. Will. 1999. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274:12555-12566.
40. Szostecki, C., H. H. Guldner, H. J. Netter, and H. Will. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:4338-4347.
41. Tarsounas, M., P. Munoz, A. Claas, P. G. Smiraldo, D. L. Pittman, M. A. Blasco, and S. C. West. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117:337-347.
42. Teng, S.-C., J. Chang, B. McCowan, and V. A. Zakian. 2000. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6:947-952.
43. Teng, S.-C., and V. A. Zakian. 1999. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:8083-8093.
44. Toouli, C. D., L. I. Huschtscha, A. A. Neumann, J. R. Noble, L. M. Colgin, B. Hukku, and R. R. Reddel. 2002. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene 21:128-139.
45. Ulaner, G. A., H. Y. Huang, J. Otero, Z. Zhao, L. Ben-Porat, J. M. Satagopan, R. Gorlick, P. Meyers, J. H. Healey, A. G. Huvos, A. R. Hoffman, and M. Ladanyi. 2003. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 63:1759-1763.
46. Usui, T., T. Ohta, H. Oshiumi, J. Tomizawa, H. Ogawa, and T. Ogawa. 1998. Complex formation and functional versatility of Mre11 of budding yeast in recombination. Cell 95:705-716.
47. Wasylyk, C., S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk. 2002. Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol. Cell. Biol. 22:2687-2702.
48. Wiesmeijer, K., C. Molenaar, I. M. Bekeer, H. J. Tanke, and R. W. Dirks. 2002. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140:180-188.
49. Wu, G., X. Jiang, W. H. Lee, and P. L. Chen. 2003. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63:2589-2595.
50. 2 phases in immortalized telomerase-negative cells: Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275:30618-30622.
51. Yankiwski, V., R. A. Marciniak, L. Guarente, and N. F. Neff. 2000. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97:5214-5219.
52. Yeager, T. R., A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble, and R. R. Reddel. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59:4175-4179.
53. Zhong, S., P. Salomoni, and P. P. Pandolfi. 2000. The tianscriptional role of PML and the nuclear body. Nat. Cell Biol. 2:E85-E90.
54. Zhu, X. D., L. Niedernhofer, B. Kuster, M. Mann, J. H. Hoeijmakers, and T. de Lange. 2003. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12:1489-1498.
55. Zhu, X.-D., B. Kuster, M. Mann, J. H. J. Petrini, and T. de Lange. 2000. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25:347-352.